关注
Simon Papillon-Cavanagh
Simon Papillon-Cavanagh
Bristol Myers Squibb
在 mail.mcgill.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
AM Fontebasso, S Papillon-Cavanagh, J Schwartzentruber, H Nikbakht, ...
Nature genetics 46 (5), 462-466, 2014
4442014
The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape
DN Weinberg, S Papillon-Cavanagh, H Chen, Y Yue, X Chen, ...
Nature 573 (7773), 281-286, 2019
4122019
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape
C Lu, SU Jain, D Hoelper, D Bechet, RC Molden, L Ran, D Murphy, ...
Science 352 (6287), 844-849, 2016
3812016
H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis
AS Harutyunyan, B Krug, H Chen, S Papillon-Cavanagh, M Zeinieh, ...
Nature communications 10 (1), 1262, 2019
2732019
mRMRe: an R package for parallelized mRMR ensemble feature selection
N De Jay, S Papillon-Cavanagh, C Olsen, N El-Hachem, G Bontempi, ...
Bioinformatics 29 (18), 2365-2368, 2013
2592013
Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma
H Nikbakht, E Panditharatna, LG Mikael, R Li, T Gayden, M Osmond, ...
Nature communications 7 (1), 11185, 2016
2402016
Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas
S Papillon-Cavanagh, C Lu, T Gayden, LG Mikael, D Bechet, ...
Nature genetics 49 (2), 180-185, 2017
2352017
Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR
CL Kleinman, N Gerges, S Papillon-Cavanagh, P Sin-Chan, ...
Nature genetics 46 (1), 39-44, 2014
2142014
STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
S Papillon-Cavanagh, P Doshi, R Dobrin, J Szustakowski, AM Walsh
ESMO open 5 (2), e000706, 2020
1702020
Mutations in C5ORF42 cause Joubert syndrome in the French Canadian population
M Srour, J Schwartzentruber, FF Hamdan, LH Ospina, L Patry, D Labuda, ...
The American Journal of Human Genetics 90 (4), 693-700, 2012
1432012
Spatial heterogeneity in medulloblastoma
AS Morrissy, FMG Cavalli, M Remke, V Ramaswamy, DJH Shih, ...
Nature genetics 49 (5), 780-788, 2017
1412017
The molecular landscape of ETMR at diagnosis and relapse
S Lambo, SN Gröbner, T Rausch, SM Waszak, C Schmidt, A Gorthi, ...
Nature 576 (7786), 274-280, 2019
1202019
Mutation in The Nuclear‐Encoded Mitochondrial Isoleucyl–tRNA Synthetase IARS2 in Patients with Cataracts, Growth Hormone Deficiency with Short Stature …
J Schwartzentruber, D Buhas, J Majewski, F Sasarman, ...
Human mutation 35 (11), 1285-1289, 2014
942014
Comparison and validation of genomic predictors for anticancer drug sensitivity
S Papillon-Cavanagh, N De Jay, N Hachem, C Olsen, G Bontempi, ...
Journal of the American Medical Informatics Association 20 (4), 597-602, 2013
822013
Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma
RJ Motzer, TK Choueiri, DF McDermott, T Powles, YA Vano, S Gupta, ...
Journal for ImmunoTherapy of Cancer 10 (3), 2022
642022
Mutations in a novel serine protease PRSS56 in families with nanophthalmos
A Orr, MP Dubé, JC Zenteno, H Jiang, G Asselin, SC Evans, A Caqueret, ...
Molecular vision 17, 1850, 2011
582011
Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors
AM Fontebasso, T Gayden, H Nikbakht, M Neirinck, S Papillon-Cavanagh, ...
Acta neuropathologica 128, 615-627, 2014
472014
Biomarker analyses from the phase III CheckMate 214 trial of nivolumab plus ipilimumab (N+ I) or sunitinib (S) in advanced renal cell carcinoma (aRCC).
RJ Motzer, TK Choueiri, DF McDermott, T Powles, J Yao, R Ammar, ...
Journal of Clinical Oncology 38 (15_suppl), 5009-5009, 2020
432020
Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC
P Ross-Macdonald, AM Walsh, SD Chasalow, R Ammar, ...
Journal for immunotherapy of cancer 9 (3), 2021
282021
A multi‐omic single cell sequencing approach to develop a CD8 T cell specific gene signature for anti‐PD1 response in solid tumors
N Kumar, S Papillon‐Cavanagh, H Tang, S Wang, C Stromko, CP Ho, ...
International journal of cancer 151 (11), 2043-2054, 2022
42022
系统目前无法执行此操作,请稍后再试。
文章 1–20